slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.943 KRW | -0,46% | -11,68% | -42,51% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
T-cell Therapy and Antibody Therapeutics
100,0
%
| 216 | 100,0 % | 132 | 100,0 % | -38,95% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
70,1
%
| 216 | 100,0 % | 92 | 70,1 % | -57,18% |
China
29,9
%
| - | - | 39 | 29,9 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Soo-Young Choi
CEO | Chief Executive Officer | 63 | 01-03-20 |
Byoung Kwon
FOU | Founder | 77 | 27-02-15 |
Guk-Hee Lee
AUD | Comptroller/Controller/Auditor | 76 | 01-12-16 |
Young-Ho Kim
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yong-Sang Cho
BRD | Director/Board Member | 76 | 28-12-18 |
Byoung Kwon
FOU | Founder | 77 | 27-02-15 |
Myung-Hee Han
BRD | Director/Board Member | 76 | 28-12-18 |
Young-Ho Kim
PRN | Corporate Officer/Principal | - | - |
Bin Heo
BRD | Director/Board Member | 48 | - |
Jang-Woo Park
BRD | Director/Board Member | 75 | 01-03-18 |
Soo-Young Choi
CEO | Chief Executive Officer | 63 | 01-03-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 47 471 | 0 | 2 ( 0,004213 %) | 70,21 % |
Aandeel B | 1 | 36 798 858 | 25 836 762 ( 70,21 %) | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
EUTILEX.CO.,LTD 0.01% | 3 977 | 0.01% | 6 359 $ |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,51% | 52,62 mln. | |
-2,95% | 90,75 mld. | |
-1,97% | 39,03 mld. | |
-15,47% | 31,85 mld. | |
+62,42% | 26,26 mld. | |
-22,81% | 14,13 mld. | |
-8,82% | 12,87 mld. | |
-11,77% | 11,6 mld. | |
-45,97% | 10,91 mld. | |
+3,00% | 8,89 mld. |
- Beurs
- Aandelen
- Koers A263050
- Onderneming Eutilex.Co.,Ltd